178 related articles for article (PubMed ID: 36313303)
1. Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation.
Wei Y; Wu D; Chen Y; Dong C; Qi J; Wu Y; Cai R; Zhou S; Li C; Niu L; Wu T; Xiao Y; Liu T
Front Pharmacol; 2022; 13():1002628. PubMed ID: 36313303
[No Abstract] [Full Text] [Related]
2. Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients.
Xiang H; Zhou H; Zhang J; Sun Y; Wang Y; Han Y; Cai J
Front Pharmacol; 2021; 12():652333. PubMed ID: 33912061
[No Abstract] [Full Text] [Related]
3. Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.
Zhao W; Fakhoury M; Deschênes G; Roussey G; Brochard K; Niaudet P; Tsimaratos M; André JL; Cloarec S; Cochat P; Bensman A; Azougagh S; Jacqz-Aigrain E
J Clin Pharmacol; 2010 Nov; 50(11):1280-91. PubMed ID: 20147615
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies.
Wang X; Wu Y; Huang J; Shan S; Mai M; Zhu J; Yang M; Shang D; Wu Z; Lan J; Zhong S; Wu M
Front Pharmacol; 2021; 12():748609. PubMed ID: 34867352
[No Abstract] [Full Text] [Related]
5. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen.
Reséndiz-Galván JE; Romano-Aguilar M; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Jung-Cook H; Chevaile-Ramos JA; Romano-Moreno S
Eur J Pharm Sci; 2020 Jul; 150():105370. PubMed ID: 32387086
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus.
Wang K; Feng L; Zhang J; Zou Q; Xu F; Sun Z; Tang F; Chen L
Clin Pharmacokinet; 2023 Oct; 62(10):1413-1425. PubMed ID: 37537410
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Mathot RA
Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.
Romano-Aguilar M; Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Martínez-Martínez MU; Abud-Mendoza C; Romano-Moreno S
Lupus; 2020 Aug; 29(9):1067-1077. PubMed ID: 32539658
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.
Zhao W; Elie V; Baudouin V; Bensman A; André JL; Brochard K; Broux F; Cailliez M; Loirat C; Jacqz-Aigrain E
Br J Clin Pharmacol; 2010 Apr; 69(4):358-66. PubMed ID: 20406220
[TBL] [Abstract][Full Text] [Related]
13. UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
Fukuda T; Goebel J; Cox S; Maseck D; Zhang K; Sherbotie JR; Ellis EN; James LP; Ward RM; Vinks AA
Ther Drug Monit; 2012 Dec; 34(6):671-9. PubMed ID: 23131697
[TBL] [Abstract][Full Text] [Related]
14. Body Surface Area-Based Dosing of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Prospective Population Pharmacokinetic Study.
Park HJ; Hong KT; Han N; Kim IW; Oh JM; Kang HJ
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140082
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
Barau C; Furlan V; Debray D; Taburet AM; Barrail-Tran A
Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
[TBL] [Abstract][Full Text] [Related]
17. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients.
Rexiti K; Jiang X; Kong Y; Chen X; Liu H; Peng H; Wei X
Xenobiotica; 2023; 53(10-11):603-612. PubMed ID: 37991412
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of topiramate in Chinese children with epilepsy.
Wei S; Li X; Zhang Q; Wu H; Wu Y; Zhao Z; Mei S; Feng W
Eur J Clin Pharmacol; 2023 Oct; 79(10):1401-1415. PubMed ID: 37597080
[TBL] [Abstract][Full Text] [Related]
20. UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
van Schaik RH; van Agteren M; de Fijter JW; Hartmann A; Schmidt J; Budde K; Kuypers D; Le Meur Y; van der Werf M; Mamelok R; van Gelder T
Clin Pharmacol Ther; 2009 Sep; 86(3):319-27. PubMed ID: 19494809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
